Collagen Matrix, a provider of products and technology used in tissue repair and regeneration, has been acquired by Metalmark Capital. Collagen Matrix’s management team, including founder, Dr. Shu-Tung Li, will remain with the company.
Collagen Matrix designs and engineers collagen and other mineral-based extracellular matrices for tissue and organ repair and regeneration. The company manufactures more than 30 types of medical devices that are used in the areas of orthopedic-spine surgery, neurosurgery, oral surgery and wound care. Collagen’s products are sold in more than forty countries worldwide. The company operates a 28,000 sq. ft. manufacturing facility in Oakland, NJ (headquarters).The company was founded by Dr. Shu-Tung Li in 1997 (www.collagenmatrix.com).
“Under the leadership of Dr. Shu-Tung Li, Collagen Matrix has become an industry leader that designs, develops, manufactures and markets high quality collagen- and mineral-based products, all of which are delivered through exemplary customer service,” said Fazle Husain, Managing Director at Metalmark Capital. “We look forward to partnering with the Collagen Matrix management team to support the company in raising its existing business and proprietary technology to a higher level of world-class leadership. This investment broadens Metalmark’s presence in medical devices and strengthens our portfolio in healthcare, an important growth area for the firm.”
Metalmark Capital was established by the principals of Morgan Stanley Capital Partners (MSCP) to manage the Metalmark Capital and MSCP funds. Since 1986, the Metalmark Capital and MSCP funds have invested $7 billion of equity capital in over 100 companies. Sectors of interest include healthcare, energy and industrials. Metalmark Capital is currently investing through its latest fund that has $2.5 billion of committed capital. The firm is based in New York (www.metalmarkcapital.com).
“We are excited about this opportunity to partner with Metalmark Capital,” said Dr. Li. “Over the past 17 years, Collagen Matrix has grown into a leading medical technology company with innovation at the heart of our work. Metalmark’s partnership brings a strong knowledge of the sector as well as access to additional capital and resources that will advance the next chapter of our growth and expand our leadership role in tissue repair and regeneration.”
RBC Capital Markets acted as financial advisor and Skadden, Arps, Slate, Meagher & Flom acted as legal advisor to Collagen Matrix on this transaction. Ropes & Gray acted as legal advisor to Metalmark Capital.
2014 PEPD • Private Equity’s Leading News Magazine • 10-26-14